UCSD researchers find FAK protein linked to chemotherapy resistance in ovarian cancer
Published - 09/12/19 - 09:00 AM | 1372 views | 3 3 comments | 19 19 recommendations | email to a friend | print

Although the number of women being diagnosed and dying of ovarian cancer is declining, recurrence, drug resistance, and mortality remains high for women with high-grade serous ovarian carcinoma, the most common form of epithelial ovarian cancer.  

A new study in the journal eLife by University of California San Diego School of Medicine researchers links changes in the gene for the protein focal adhesion kinase, or FAK, to the cancer’s ability to survive chemotherapy.

“We have linked elevated levels of FAK, or gene amplification, to the survival of cancer stem cells in a new tumor model,” said David D. Schlaepfer, PhD, a professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at UC San Diego School of Medicine, a UC San Diego Moores Cancer Center researcher and co-principal investigator.  

“This was not expected. We knew FAK helped tumors to spread, but we were surprised to find that FAK supports DNA repair in the most important stem-like cells of the tumor. This may be an important tool that tumors use to resist platinum chemotherapy, which is the current standard of care.”

In the majority of patients, ovarian tumors exhibit high levels of FAK, said Dwayne G. Stupack, PhD, an associate professor in the Division of Gynecologic Oncology at Moores Cancer Center and co-principal investigator.   

“There are drugs being tested in early phase clinical trials, including at UC San Diego Health, that inhibit FAK,” said Stupack. “When we treated mice that had chemo-resistant tumors with a FAK inhibitor they responded to chemotherapy. Mice that did not receive the FAK inhibitor were resistant. By understanding the biology behind this, it can help us prepare better combinations of drugs for the clinic.”

The ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK, led by Michael McHale, MD, — professor in the UC San Diego School of Medicine Department of Obstetrics, Gynecology and Reproductive Sciences and chief of the Division of Gynecologic Oncology Services at UC San Diego Health — is investigating the combination of the investigational FAK inhibitor defactinib with the chemotherapy drugs carboplatin and paclitaxel for patients with chemo-resistant ovarian cancer.

“If we can prevent recurrence, we may be able to provide great benefit to patients,” said McHale, a co-author on the study. 

The National Cancer Institute (NCI) estimates that 22,350 women will be diagnosed with ovarian cancer in 2019, and 13,980 will die. Approximately 1 in 70 women will be diagnosed with this disease in their lifetime. Breast cancer affects nine times more women than ovarian cancer, but according to the NCI, almost nine out of 10 women will survive five years or longer with breast cancer. More than half of women with ovarian cancer will die within five years of diagnosis. 

Cure or remission is dependent on the elimination of all cancer cells, including microscopic disease. Ovarian cancer cells often spread to other parts of a woman’s body before an official diagnosis. The cells can grow as tiny clumps or as larger balls, called tumorspheres. In the majority of patients, ovarian cancer cells develop chemotherapy resistance.

The collaborative study, led by Schlaepfer and Stupack, focused on high-grade serous ovarian carcinoma, a subtype of epithelial cancer that starts in the outer surface of the ovaries or fallopian tubes. It makes up approximately 52% of malignant ovarian cancer and accounts for the highest number of deaths. 

Researchers compared ovarian cancer cells in mouse models at early and late stages of the disease. The late-stage, aggressive cells exhibited greater genetic changes and could grow as tumorspheres in lab dishes. One of these changes affected the gene for FAK, which was found to have more copies than normal.

The FAK protein is an enzyme that helps cancer cells move around. In cells from mice with late-stage cancer, FAK was over-active and present at high levels. When grown as tumorspheres, the FAK-overactive tumors were more resistant to chemotherapy than their early-stage counterparts. Among patients who had received chemotherapy, the team found that surviving tumor cells also displayed high levels of FAK activity. 

To understand how FAK makes ovarian cancer cells resistant to chemotherapy, the researchers used gene-editing to delete the FAK gene. They found that, without FAK, cells became deficient in a group of detoxifying enzymes as well as others that repair damaged DNA.

“Patients with ovarian cancer generally respond well to first-line therapy, but in most cases, the cancer returns,” said Schlaepfer.

“We know that a subpopulation of stem-like cancer cells can survive chemotherapy and lead to recurrence, drug resistance and even death,” said Schlaepfer. “These findings suggest FAK is an important and potential therapeutic vulnerability underlying tumor recurrence.” 

For the full study, visit https://doi.org/10.7554/eLife.47327.

Comments
(3)
Comments-icon Post a Comment
donald sharrel
|
September 14, 2019


my ex boyfriend Peter and I.have been dating for 8 months, and we have been talking about getting married and spending the rest of our lives together. But things started to changed Peter he isn’t willingly to be fully committed relationship and every time we talk about these things with each other he keeps walking away and gets upset about it. also i was heartbroken,

Thanks to the internet which has seems to have made everything more easy and possibilities to come out of difficult issues. At first when peter

left me i didn’t have any idea on how to restore my relationship back, But through the internet i was able to get the details of this powerful spell caster

called Dr.Noble whose details are:templeofjoyandprosperity1@gmail.com Call or WhatsApp: 2348145643630

Whom i contacted and my broken relationship became restored within 11 hours,thanks Dr.
Theresa Bartman
|
September 12, 2019
My name is Theresa Bartman and it's been 2 months since Dr. Maleek saved me from stage 5 breast cancer. i have been suffering from this disease for a long time, my breast was totally out of shape I had pains throughout my body. one day i saw his contact on the internet how he saved a young woman i have no option anymore i quickly took his contact and contacted him and he responded to me and told me what to do and i followed all his instructions after that the cure was sent to me through DHL and after I took the medication, i felt life in my body again and i was totally recovered. I am here to thank you and let people know that cancer can be cured. Contact him at:

ultimateherbalcure@gmail.com

Whats-app Contact is: 2348139565427
ANITA DELPH
|
September 13, 2019
After my boyfriend of one year broke up with me, I could barely speak without crying. I felt blindsided and didn't know what to do. I didn't know if I could get him back and the anxiety was unbearable. I needed him back desperately because i loved him so much. So i contacted this great spell caster for help. He helped me cast a return love spell on him and just within 48 hours my boyfriend came back to me crying and begging for my forgiveness. Dr Larry released him to know how much i loved and wanted him. And He also opened his eyes to picture how much love we have share together. As I am writing this testimony right now i am the most happiest woman on earth. I want to recommend this great spell caster to anyone that truly needs an urgent solution to a love break up Email him at assurancesolutionhome@gmail.com or Call/WhatsApp him: 1(424)-261-8520 "I'm so grateful and can say that if you have been broken up with and want to get that person back, Dr Larry is the best! I'll never forget how much he helped me  website http://assurancesolutionhome.wordpress.com  http://assurancesolutionhome.website2.me/
Comments are back! Simply post the comment (it'll complain about you failing the human test) then simply click on the captcha and then click "Post Comment" again. Comments are also welcome on our Facebook page.
Trending